Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 3
Submit an article Journal homepage
2,122
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models

Grammatiki FotakiDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenView further author information
,
Chuan JinDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenView further author information
,
Iliana Kyriaki KerzeliDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenView further author information
,
Mohanraj RamachandranDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenView further author information
,
Minttu-Maria MartikainenDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenView further author information
,
Alex Karlsson-ParraDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;Immunicum AB, Gothenburg SwedenView further author information
,
Di YuDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-8636-0351View further author information
ORCID Icon &
Magnus EssandDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, SwedenView further author information
 show all
Article: e1397250 | Received 23 Aug 2017, Accepted 21 Oct 2017, Published online: 26 Dec 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Aurélie Collignon, Françoise Silvy, Stéphane Robert, Malika Trad, Sébastien Germain, Jérémy Nigri, Frédéric André, Véronique Rigot, Richard Tomasini, Bernard Bonnotte, Dominique Lombardo, Eric Mas & Evelyne Beraud. (2018) Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. OncoImmunology 7:12.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.